Dipeptidyl peptidase-4 (DPP-4) inhibitor and mortality in coronavirus disease 2019 (COVID-19) – A systematic review, meta-analysis, and meta-regression
Iis Inayati Rakhmat, Yudith Yunia Kusmala, Dewi Ratih Handayani, Henny Juliastuti, Eka Noneng Nawangsih, Arief Wibowo, Michael Anthonius Lim, Raymond Pranata
Topics & Concepts
MedicineDipeptidyl peptidase-4ACE inhibitorInternal medicineMeta-analysisDipeptidyl peptidase-4 inhibitorMeta-regressionMetforminRelative riskRandomized controlled trialAngiotensin-converting enzymePharmacologyGastroenterologyEndocrinologyType 2 diabetesConfidence intervalDiabetes mellitusInsulinBlood pressureCOVID-19 Clinical Research StudiesPeptidase Inhibition and AnalysisDiabetes Treatment and Management